PlainRecalls
FDA Drug Low Class III Ongoing

Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (NDC 59148-008-95), RX only, Otsuka America Pharmaceutical, Inc.

Reported: May 1, 2024 Initiated: April 9, 2024 #D-0467-2024

Product Description

Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (NDC 59148-008-95), RX only, Otsuka America Pharmaceutical, Inc.

Reason for Recall

Cross Contamination with Other Products

Details

Units Affected
N/A
Distribution
USA nationwide.
Location
Tokushima, N/A

Frequently Asked Questions

What product was recalled?
Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (NDC 59148-008-95), RX only, Otsuka America Pharmaceutical, Inc.. Recalled by Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.. Units affected: N/A.
Why was this product recalled?
Cross Contamination with Other Products
Which agency issued this recall?
This recall was issued by the FDA Drug on May 1, 2024. Severity: Low. Recall number: D-0467-2024.